Cormorant Asset Management, LP - 10%+ Owner at Ambrx Biopharma Cayman, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
AMAM
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Cormorant Asset Management, LP since 14 Feb 2025

Holdings reported by Cormorant Asset Management, LP for Ambrx Biopharma Cayman, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Ordinary Shares 62,097,896 $662,764,634 $10.67 17 Apr 2023 Indirect

Transactions reported by Cormorant Asset Management, LP for Ambrx Biopharma Cayman, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.